UPDATE - UBS Initiates Coverage on LifePoint Hospitals (LPNT) with a Neutral; Unique Portfolio, Strong Balance Sheet and M&A Pipeline
Tweet Send to a FriendGet Alerts LPNT Hot Sheet
Price: $48.11 +0.04%
Rating Summary:
6 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
6 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade LPNT Now!
UPDATE - UBS initiates coverage on LifePoint Hospitals (Nasdaq: LPNT) with a Neutral. PT $43.
Analyst, A.J. Rice, said, "We like the LPNT story but will wait for a better entry point given the shares’ strong relative performance over the last 18 months. Our price target assumes LPNT shares trade at 6.0x our 2013 EBITDA estimate, which is in line with the company’s five year average valuation."
"LPNT enjoys one of the strongest balance sheets among publicly traded hospital operators, with net debt to LTM EBITDA of 2.8x. We believe LPNT has ample liquidity to execute on its plan to grow both organically and through acquisitions."
To see more ratings on LPNT, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, A.J. Rice, said, "We like the LPNT story but will wait for a better entry point given the shares’ strong relative performance over the last 18 months. Our price target assumes LPNT shares trade at 6.0x our 2013 EBITDA estimate, which is in line with the company’s five year average valuation."
"LPNT enjoys one of the strongest balance sheets among publicly traded hospital operators, with net debt to LTM EBITDA of 2.8x. We believe LPNT has ample liquidity to execute on its plan to grow both organically and through acquisitions."
To see more ratings on LPNT, Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Topeka Capital Starts Atmel (ATML) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
